PUBLICATIONS

Annane D, Timsit JF, Megarbane B, Martin C, Misset B, Mourvillier B, Siami S, Chagnon JL, Constantin JM, Petitpas F, Souweine B, Amathieu R, Forceville X, Charpentier C, Tesnière A, Chastre J, Bohe J, Colin G, Cariou A, Renault A, Brun-Buisson C, Bellissant E; APROCCHSS Trial Investigators. Recombinant human activated protein C for adults with septic shock. Am J Respir Crit Care Med. 2013 May 15;187(10):1091-7. doi: 10.1164/rccm.201211-2020OC.

 

*Baraniak A, Izdebski R, Fiett J, Sadowy E, Adler A, Kazma M, Salomon J, Lawrence C, Rossini A, Salvia A, Vidal Samso J, Fierro J, Paul M, Lerman Y, Malhotra-Kumar S, Lammens C, Goossens H, Hryniewicz W, Brun-Buisson C, Carmeli Y, Gniadkowski M; MOSAR WP2 and WP5 Study Groups. Comparative population analysis of Klebsiella pneumoniae strains with extended-spectrum β-lactamases colonizing patients in rehabilitation centers in four countries. Antimicrob Agents Chemother. 2013 Apr;57(4):1992-7. doi: 10.1128/AAC.02571-12.

 

Brun-Buisson C, Schortgen F. Sedation interruption for mechanically ventilated patients. JAMA. 2013 Mar 13;309(10):981. doi: 10.1001/jama.2013.995.

 

Brun-Buisson C, Razazi K, Derde LP, Bonten MJ. Control of colonisation with extended-spectrum β-lactamase-producing bacteria: reply to Zandstra et al. Intensive Care Med. 2013 Mar;39(3):540. doi: 10.1007/s00134-012-2781-z.

 

*Catherinot E, Roux AL, Vibet MA, Bellis G, Ravilly S, Lemonnier L, Le Roux E, Bernède-Bauduin C, Le Bourgeois M, Herrmann JL, Guillemot D, Gaillard JL; For the OMA group. Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations. J Cyst Fibros. 2013 Jan;12(1):74-80. doi: 10.1016/j.jcf.2012.06.009.

 

Cormier F, Monjanel H, Fabre C, Billot K, Sapharikas E, Chereau F, Bordereaux D, Molina TJ, Avet-Loiseau H, Baud V. Frequent engagement of RelB activation is critical for cell survival in multiple myeloma. PLoS One. 2013;8(3):e59127. doi: 10.1371/journal.pone.0059127.

 

*David JM, Guillemot D, Bemrah N, Thébault A, Brisabois A, Chemaly M, Weill F, Sanders P, Watier L. The bayesian microbial subtyping attribution model: robustness to prior information and a proposition. Risk Anal. 2013 Mar;33(3):397-408. doi: 10.1111/j.1539-6924.2012.01877.x.

 

*David JM, Sanders P, Bemrah N, Granier SA, Denis M, Weill FX, Guillemot D, Watier L. Attribution of the French human Salmonellosis cases to the main food-sources according to the type of surveillance data. Prev Vet Med. 2013 May 15;110(1):12-27. doi: 10.1016/j.prevetmed.2013.02.002.

 

de Truchis P, Davido B, El Sayed F, Roux AL, Sow MS, Perronne C, Melchior JC. Pasteurella infection after muraenidae bite in an HIV infected patient. Travel Med Infect Dis. 2013 Apr 19. pii: S1477-8939(13)00020-3. doi: 10.1016/j.tmaid.2013.03.001.

 

*Domenech de Cellès M, Zahar JR, Abadie V, Guillemot D. Limits of patient isolation measures to control extended-spectrum beta-lactamase-producing Enterobacteriaceae: model-based analysis of clinical data in a pediatric ward. BMC Infect Dis. 2013 Apr 24;13:187. doi: 10.1186/1471-2334-13-187.

 

*Gaud G, Guillemot D, Jacob Y, Favre M, Vuillier F. EVER2 protein binds TRADD to promote TNF-α-induced apoptosis. Cell Death Dis. 2013 Feb 21;4:e499. doi: 10.1038/cddis.2013.27.

 

*Grimaldi-Bensouda L, Zureik M, Aubier M, Humbert M, Levy J, Benichou J, Molimard M, Abenhaim L; Pharmacoepidemiology of Asthma and Xolair (PAX) Study Group. Does omalizumab make a difference to the real-life treatment of asthma exacerbations?: Results from a large cohort of patients with severe uncontrolled asthma. Chest. 2013 Feb 1;143(2):398-405. doi: 10.1378/chest.12-1372.

 

*Grimaldi-Bensouda L, Aubrun E, Leighton P, Benichou J, Rossignol M, Abenhaim L; PGRx Study Group. Agreement between patients’ self-report and medical records for vaccination: The PGRx database. Pharmacoepidemiol Drug Saf. 2013 Mar;22(3):278-85. doi: 10.1002/pds.3401.

 

*Izdebski R, Baraniak A, Fiett J, Adler A, Kazma M, Salomon J, Lawrence C, Rossini A, Salvia A, Vidal Samso J, Fierro J, Paul M, Lerman Y, Malhotra-Kumar S, Lammens C, Goossens H, Hryniewicz W, Brun-Buisson C, Carmeli Y, Gniadkowski M; MOSAR WP2 and WP5 Study Groups. Clonal structure, extended-spectrum β-lactamases, and acquired AmpC-type cephalosporinases of Escherichia coli populations colonizing patients in rehabilitation centers in four countries. Antimicrob Agents Chemother. 2013 Jan;57(1):309-16. doi: 10.1128/AAC.01656-12.

 

Landelle C, Legrand P, Lesprit P, Cizeau F, Ducellier D, Gouot C, Bréhaut P, Soing-Altrach S, Girou E, Brun-Buisson C. Protracted outbreak of multidrug-resistant Acinetobacter baumannii after intercontinental transfer of colonized patients. Infect Control Hosp Epidemiol. 2013 Feb;34(2):119-24. doi: 10.1086/669093.

 

Lesprit P, Landelle C, Brun-Buisson C. Clinical impact of unsolicited post-prescription antibiotic review in surgical and medical wards: a randomized controlled trial. Clin Microbiol Infect. 2013 Feb;19(2):E91-7. doi: 10.1111/1469-0691.12062.

 

Lesprit P, Landelle C, Brun-Buisson C. Unsolicited post-prescription antibiotic review in surgical and medical wards: factors associated with counselling and physicians' compliance. Eur J Clin Microbiol Infect Dis. 2013 Feb;32(2):227-35. doi: 10.1007/s10096-012-1734-3.

 

Munier A, Marzouk D, Abravanel F, El-Daly M, Taylor S, Mamdouh R, Eldin WS, El-Arab HE, Sos DG, Momen M, Okasha O, Le Fouler L, El-Hosini M, Izopet J, Rafik M, Albert M, Abdel-Hamid M, Mohamed MK, Delarocque-Astagneau E, Fontanet A. Frequent transient hepatitis C viremia without seroconversion among healthcare workers in Cairo, Egypt. PLoS One. 2013;8(2):e57835. doi: 10.1371/journal.pone.0057835.

 

Pham T, Combes A, Rozé H, Chevret S, Mercat A, Roch A, Mourvillier B, Ara-Somohano C, Bastien O, Zogheib E, Clavel M, Constan A, Marie Richard JC, Brun-Buisson C, Brochard L; REVA Research Network. Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: a cohort study and propensity-matched analysis. Am J Respir Crit Care Med. 2013 Feb 1;187(3):276-85. doi: 10.1164/rccm.201205-0815OC.

 

 

*Verdoux H, Gaudron Y, Auleley GR, Deligne J, Blum-Boisgard C, Thiébaut ACM, Tournier M. Surveillance métabolique biologique après initiation d'un traitement antipsychotique chez des personnes traitées par lithium ou anticonvulsivants [Metabolic testing rates after initiation of antipsychotic treatment in persons initially treated by conventional mood-stabilizers.] Encéphale. 2013 May;39 (supplt 1):S22—28. doi: 10.1016/j.encep.2012.10.009.